Form 4: SeaStar Medical Director Acquires 4,000 Restricted Stock Units

SeaStar Medical Holding Corp director Kenneth Van Heel acquired 4,000 restricted stock units on November 13, 2024, which will vest on June 4, 2025.

Summary

• Kenneth Van Heel, a director at SeaStar Medical Holding Corp, acquired 4,000 restricted stock units on November 13, 2024.
• These restricted stock units represent a contingent right to receive one share of ICU common stock each.
• The restricted stock units will vest 100% on June 4, 2025.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of a director's stock unit acquisition. It is neither particularly positive nor negative, but indicates continued alignment of interests.

Positives

• The acquisition of restricted stock units by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's stock. It is a routine disclosure and does not indicate any unusual activity.

Comparison to Industry Standards

• Stock-based compensation is a common practice for publicly traded companies to align the interests of management and directors with those of shareholders.
• The vesting schedule of approximately 7 months is within the typical range for such grants.

Stakeholder Impact

• The acquisition of restricted stock units by a director can be seen as a positive sign by shareholders, indicating confidence in the company's future.

Key Dates

Keywords

restricted stock units, insider trading, SeaStar Medical, ICU, director, equity compensation, stock options